Where Risk Meets Opportunity: Strategies for MedTech Success

The Emerging Biotech Leader

Content provided by SSI Strategy. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by SSI Strategy or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

8M ago 44:57

MP3•Episode home

This episode offers critical insights on leveraging risk management as a strategic advantage in medical device development. In a conversation with Ramin Farhood, Bijan Elahi, with over 30 years of experience, provides a roadmap for integrating safety considerations into innovation pipelines, potentially accelerating time-to-market and enhancing competitive positioning.

Key Strategic Takeaways:

Early integration of risk management, starting at the concept stage, can significantly reduce costs and accelerate time-to-market. This approach can level the playing field between firms of different sizes and serve as a market differentiator.

Bijan emphasizes the balance between innovation and safety, noting that firms demonstrating significant benefits, especially in underserved areas, may find more regulatory flexibility.

Risk-based approaches are increasingly expected across all business operations. Implementing this holistically can improve efficiency and reduce vulnerabilities in supply chain and manufacturing processes.

Strategic Implications:

Prioritize early investment in risk management capabilities for long-term cost savings and faster market entry. Consider risk management expertise in key hires and partnership decisions.

Use risk management insights to refine product pipeline strategy, focusing resources on projects with the highest likelihood of regulatory success and market acceptance.

Foster a company-wide culture of safety and risk awareness. This aligns with regulatory expectations and can drive responsible innovation.

Robust risk management practices can serve as a powerful narrative for investors, demonstrating foresight and responsible innovation.

By integrating these insights, companies can potentially accelerate development timelines, enhance their competitive position, and build a reputation for responsible innovation that resonates with regulators, partners, and customers alike.

Are you leading a biotech and would like to share your experience with our podcast audience? We'd love to hear from you! Please reach out to us.

47 episodes

#Business #SSI Strategy #Science #Biology #Biotechnology #Biotech Startups #Biotech Product Launch #Chief Medical Officer #Biotech Executive #Biotech Leadership